Back to Research Hub
Baxter International Inc.
BAX
$20.03+0.79 (+4.11%)
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices;…
StreetsValue research for Baxter International Inc. (BAX)
Members get the full report for Baxter International Inc.: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.